scispace - formally typeset
R

Raúl G. Barletta

Researcher at University of Nebraska–Lincoln

Publications -  82
Citations -  6182

Raúl G. Barletta is an academic researcher from University of Nebraska–Lincoln. The author has contributed to research in topics: Paratuberculosis & Mycobacterium smegmatis. The author has an hindex of 34, co-authored 78 publications receiving 5844 citations. Previous affiliations of Raúl G. Barletta include Albert Einstein College of Medicine & Yeshiva University.

Papers
More filters
Journal ArticleDOI

New use of BCG for recombinant vaccines.

TL;DR: Extrachromosomal and integrative expression vectors carrying the regulatory sequences for major BCG heat-shock proteins have been developed and can elicit long-lasting humoral and cellular immune responses to foreign antigens in mice.
Journal ArticleDOI

Isolation and Characterization of Endophytic Colonizing Bacteria from Agronomic Crops and Prairie Plants

TL;DR: This study defines for the first time the endophytic nature of Microbacterium testaceum, which may be useful for biocontrol and other applications.
Journal ArticleDOI

Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 streptococcus pneumoniae

TL;DR: The antiphosphocholine antibody in normal mouse sera (NMS) provides protection against intravenous infection with encapsulated strain WU2 of type 3 Streptococcus pneumoniae.
Book ChapterDOI

Genetic Systems for Mycobacteria

TL;DR: The recent development of phage, plasmid, and gene replacement systems for the introduction of recombinant DNA into mycobacteria has opened up a new era of research on members of the genus Mycobacterium.
Journal ArticleDOI

Rapid assessment of drug susceptibilities of Mycobacterium tuberculosis by means of luciferase reporter phages

TL;DR: Luciferase reporter phages may help to reduce the time required for establishing antibiotic sensitivity of M. tuberculosis strains from weeks to days and to accelerate screening for new antituberculosis drugs.